Thoracic Aortic Aneurysm Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment, By End Use, By Region and Competition, 2020-2030F

Description

Global Thoracic Aortic Aneurysm Market was valued at USD 3.28 Billion in 2024 and is expected to reach USD 7.61 Billion by 2030 with a CAGR of 4.77%. This is driven by increasing prevalence of cardiovascular diseases, advances in diagnostic technologies, and rising awareness about early detection and treatment. Thoracic aortic aneurysm, characterized by the abnormal bulging of the aorta in the chest region, poses significant health risks including life-threatening ruptures if left untreated.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 3.28 Billion
Market Size 2030	USD 7.61 Billion
CAGR 2025-2030	4.77%
Fastest Growing Segment	Open Surgical Repair (OSR)
Largest Market	North America

Market expansion is supported by technological innovations in minimally invasive surgical techniques, such as endovascular aneurysm repair (EVAR), which offer safer and more effective treatment options compared to traditional open surgery. Key challenges include the high cost of advanced surgical procedures and devices, as well as limited accessibility to specialized healthcare facilities in certain regions, which may restrict market penetration.

Key Market Drivers

Growth in Healthcare Industry

The rapid growth of the global healthcare industry is a significant driver propelling the expansion of the thoracic aortic aneurysm (TAA) market. The global healthcare industry generates annual sales exceeding USD 4 trillion. The largest and most lucrative segments are pharmaceuticals and biotechnology, accounting for nearly USD 850 billion, and medical technology and diagnostics, which exceed USD 400 billion in revenue. Increased healthcare expenditure, advancements in diagnostic technologies, and the rising prevalence of cardiovascular diseases are collectively fueling demand for effective TAA detection and treatment solutions worldwide.

As healthcare infrastructure improves globally, more patients are gaining access to specialized cardiovascular care, leading to higher diagnosis rates and increased adoption of surgical and minimally invasive interventions for thoracic aortic aneurysms. The PEN-Plus strategy decentralizes specialized cardiovascular care to district hospitals by reallocating responsibilities to multidisciplinary teams of midlevel professionals. It aims to ensure sustainability by enhancing health literacy to encourage self-management, leveraging community health workers to improve patient retention, engaging peer-support groups, and establishing clear referral and counter-referral pathways for patients with cardiovascular disease (CVD). Furthermore, growing awareness about cardiovascular health and early screening initiatives are contributing to market growth.

Key Market Challenges

Late Diagnosis and Asymptomatic Nature

One of the primary challenges confronting the global thoracic aortic aneurysm market is the condition's asymptomatic nature, which often leads to late diagnosis. Many patients with thoracic aortic aneurysms remain unaware of their condition until symptoms manifest in advanced stages or until life-threatening complications, such as aortic rupture or dissection, occur. This silent progression significantly complicates timely intervention and treatment.

The lack of early, noticeable symptoms poses a major barrier for healthcare providers in identifying at-risk individuals before critical damage occurs. Consequently, patients frequently present with the disease at a stage when therapeutic options are more complex, invasive, and associated with higher risks. Moreover, limited awareness among the general population and inadequate routine screening protocols contribute to delayed detection.

Key Market Trends

Advanced Clinical Practices and Personalized Treatment

The adoption of advanced clinical practices and personalized treatment approaches is a key trend shaping the global thoracic aortic aneurysm (TAA) market. Open-chest thoracic aortic aneurysm repair continues to be the standard surgical treatment for thoracic aortic aneurysms (TAAs), representing the established approach for managing this condition. This procedure remains the preferred method due to its proven effectiveness in addressing complex aneurysms within the thoracic aorta. Innovations in diagnostic imaging, genetic profiling, and minimally invasive surgical techniques are enabling healthcare providers to tailor interventions more precisely to individual patient needs.

Personalized treatment strategies, supported by enhanced risk assessment tools and patient-specific data, are improving the accuracy of aneurysm detection, monitoring, and management. This approach reduces complications, optimizes therapeutic outcomes, and enhances patient quality of life. Moreover, the integration of multidisciplinary care teams and the use of advanced endovascular devices reflect a broader shift towards precision medicine in TAA treatment.

Key Market Players

Medtronic plc
W.L. Gore & Associates, Inc.
Cook Medical Inc.
Terumo Corporation
MicroPort Scientific Corporation
Boston Scientific Corporation
Artivion Inc.
Cardiatis S.A.
Endologix Inc.
Braile Biomedica

Report Scope

In this report, the Global Thoracic Aortic Aneurysm Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Thoracic Aortic Aneurysm Market, By Treatment:

Open Surgical Repair (OSR)
Thoracic Endovascular Aneurysm Repair (TEVAR)
Hybrid Procedures
Branched Endovascular Aneurysm Repair (BEVAR)
Others

Thoracic Aortic Aneurysm Market, By End Use:

Hospitals
Ambulatory surgery centers (ASC)
Clinics
Others

Thoracic Aortic Aneurysm Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Thoracic Aortic Aneurysm Market.

Available Customizations:

Global Thoracic Aortic Aneurysm Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Thoracic Aortic Aneurysm Market

5. Global Thoracic Aortic Aneurysm Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Treatment (Open Surgical Repair (OSR), Thoracic Endovascular Aneurysm Repair (TEVAR), Hybrid Procedures, Branched Endovascular Aneurysm Repair (BEVAR), Others)
- 5.2.2. By End Use (Hospitals, Ambulatory surgery centers (ASC), Clinics, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. North America Thoracic Aortic Aneurysm Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Treatment
- 6.2.2. By End Use
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Thoracic Aortic Aneurysm Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Treatment
    - 6.3.1.2.2. By End Use
- 6.3.2. Mexico Thoracic Aortic Aneurysm Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Treatment
    - 6.3.2.2.2. By End Use
- 6.3.3. Canada Thoracic Aortic Aneurysm Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Treatment
    - 6.3.3.2.2. By End Use

7. Europe Thoracic Aortic Aneurysm Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Treatment
- 7.2.2. By End Use
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Thoracic Aortic Aneurysm Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Treatment
    - 7.3.1.2.2. By End Use
- 7.3.2. Germany Thoracic Aortic Aneurysm Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Treatment
    - 7.3.2.2.2. By End Use
- 7.3.3. United Kingdom Thoracic Aortic Aneurysm Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Treatment
    - 7.3.3.2.2. By End Use
- 7.3.4. Italy Thoracic Aortic Aneurysm Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Treatment
    - 7.3.4.2.2. By End Use
- 7.3.5. Spain Thoracic Aortic Aneurysm Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Treatment
    - 7.3.5.2.2. By End Use

8. Asia Pacific Thoracic Aortic Aneurysm Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Treatment
- 8.2.2. By End Use
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Thoracic Aortic Aneurysm Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Treatment
    - 8.3.1.2.2. By End Use
- 8.3.2. India Thoracic Aortic Aneurysm Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Treatment
    - 8.3.2.2.2. By End Use
- 8.3.3. South Korea Thoracic Aortic Aneurysm Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Treatment
    - 8.3.3.2.2. By End Use
- 8.3.4. Japan Thoracic Aortic Aneurysm Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Treatment
    - 8.3.4.2.2. By End Use
- 8.3.5. Australia Thoracic Aortic Aneurysm Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Treatment
    - 8.3.5.2.2. By End Use

9. South America Thoracic Aortic Aneurysm Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Treatment
- 9.2.2. By End Use
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Thoracic Aortic Aneurysm Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Treatment
    - 9.3.1.2.2. By End Use
- 9.3.2. Argentina Thoracic Aortic Aneurysm Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Treatment
    - 9.3.2.2.2. By End Use
- 9.3.3. Colombia Thoracic Aortic Aneurysm Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Treatment
    - 9.3.3.2.2. By End Use

10. Middle East and Africa Thoracic Aortic Aneurysm Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Treatment
- 10.2.2. By End Use
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Thoracic Aortic Aneurysm Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Treatment
    - 10.3.1.2.2. By End Use
- 10.3.2. Saudi Arabia Thoracic Aortic Aneurysm Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Treatment
    - 10.3.2.2.2. By End Use
- 10.3.3. UAE Thoracic Aortic Aneurysm Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Treatment
    - 10.3.3.2.2. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Global Thoracic Aortic Aneurysm Market: SWOT Analysis

15. Porters Five Forces Analysis

15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products

16. Competitive Landscape

16.1. Medtronic plc
- 16.1.1. Business Overview
- 16.1.2. Company Snapshot
- 16.1.3. Products & Services
- 16.1.4. Financials (As Reported)
- 16.1.5. Recent Developments
- 16.1.6. Key Personnel Details
- 16.1.7. SWOT Analysis
16.2. W.L. Gore & Associates, Inc.
16.3. Cook Medical Inc.
16.4. Terumo Corporation
16.5. MicroPort Scientific Corporation
16.6. Boston Scientific Corporation
16.7. Artivion Inc.
16.8. Cardiatis S.A.
16.9. Endologix Inc.
16.10. Braile Biomedica